Samsung Bioepis Co., Ltd.

This study compares a new drug, SB27, to the approved cancer medicine Keytruda in people with early-stage non-small cell lung cancer who have already had surgery and chemotherapy. The main goal is to see if SB27 stays in the body the same way as Keytruda. About 163 participants w…

This study tests whether SB27, a biosimilar drug, works as well as Keytruda in people with advanced non-squamous non-small cell lung cancer. About 555 adults who have not had prior treatment for metastatic disease will receive either SB27 or Keytruda along with chemotherapy every…